An Indispensable Parameters of Hepatitis C Include Patho Physiology, Diagnosis, Differential Diagnosis, Treatment, Prognosis and Complications

58 million people worldwide are afflicted by the hepatitis C virus (HCV), a serious public health issue. Between 1990 and 2005, the global seropositive rate for anti-HCV antibodies is thought to have increased from 2.3% to 2.8%. When an acute infection occurs, the majority of individuals (80% to 85%) are unable to eradicate the virus and develop a chronic illness. Chronic infections can cause cirrhosis, portal hypertension, hepatocellular cancer, and hepatic decompensation with encephalopathy. Since extremely powerful direct-acting antivirals (DAAs) were introduced in 2011, the therapy landscape has changed significantly. This exercise describes the pathophysiology, assessment, and treatment of hepatitis C and emphasizes the importance of the interprofessional team in treating afflicted patients.